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 2 
SUMMARY 27 
The association of genetic polymorphisms with low bone mineral density in elite athletes have not been 28 
considered previously. The present study found that bone mass phenotypes in elite and pre-elite dancers is 29 
related to genetic variants at the Wnt/β-catenin and ER pathways.  30 
 31 
ABSTRACT 32 
Purpose Some athletes (e.g., gymnasts, dancers, swimmers) are at increased risk for low bone mineral density 33 
(BMD) which, if untreated, can lead to osteoporosis. To investigate the association of genetic polymorphisms in 34 
the oestrogen receptor (ER) and the Wnt/β-catenin signalling pathways with low BMD in elite and pre-elite 35 
dancers (impact sport athletes). 36 
Methods The study included three phases: 1) 151 elite and pre-elite dancers were screened for the presence of 37 
low BMD and traditional osteoporosis risk factors (low body weight, menstrual disturbances, low energy 38 
availability); 2) a genetic association study was conducted in 151 elite and pre-elite dancers and age- and sex-39 
matched controls; 3) serum sclerostin was measured in 101 pre-elite dancers and age- and sex-matched controls 40 
within a 3-year period. 41 
Results Eighty dancers revealed low BMD: 56.3% had at least one traditional osteoporosis risk factor, whereas 42 
28.6% did not display any risk factor (37.2% revealed traditional osteoporosis risk factors, but had normal 43 
BMD). Body weight, menstrual disturbances and energy availability did not fully predict bone mass acquisition. 44 
Instead, genetic polymorphisms in the ER and Wnt/β-catenin pathways were found to be risk factors for low 45 
BMD in elite dancers. Sclerostin was significantly increased in dancers compared to controls during the 3-year 46 
follow-up (p<0.05). 47 
Conclusions Elite and pre-elite dancers demonstrate high prevalence of low BMD, which is likely related to 48 
genetic variants at the Wnt/β-catenin and ER pathways and not to factors usually associated with BMD in 49 
athletes (body weight, menstrual disturbances, energy deficiency).  50 
Keywords BMD; athletes; sclerostin; weight-bearing; impact sports 51 
 52 
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 3 
INTRODUCTION 54 
Ample research on animal models and human populations has shown that there is a high variability in the 55 
adaptation of bone to exercise [1,2], which is modulated to a large extent by genetic factors [2,3]. Therefore, 56 
identification of single-nucleotide polymorphisms (SNPs) in genes of mechanotransduction signalling pathways 57 
can contribute to a further understanding of the factors involved in low bone mass phenotypes, particularly in 58 
individuals participating in impact sports (running, basketball, gymnastics, dancing, volleyball, etc.). The 59 
recently-described oestrogen receptor (ER) and the Wnt/β-catenin signalling pathways play key roles in bone 60 
responsiveness to mechanical loading [4,5], since osteoblast lineage cells require their full activity [6,7]. To date, 61 
our knowledge on the adaptation of bone to exercise in relation to SNPs of these pathways remains limited 62 
despite that the prevalence of low bone mineral density (BMD) remains high even in individuals participating in 63 
impact sports [8–10]. 64 
 Physical training, in general, and impact exercise, in particular, can protect against the risk of low 65 
BMD [11,12]. In accordance, the World Health Organisation issued exercise guidelines to promote bone health 66 
in both males and females [13]. Nevertheless, while impact exercise can prevent low BMD, the effects of 67 
organized impact sport training on bone health remain controversial [14,15]. For instance, some elite athletes in 68 
impact sports (particularly dancing) have lower BMD values than their non-exercising counterparts [9,10,16]. 69 
The theory currently used to explain the low BMD in these elite athletes involves mechanisms related to the 70 
growth hormone (GH) – insulin-like growth factor-I (IGF-I) axis and to the hypothalamic–hypophyseal–gonadal 71 
(HHG) axis. It has been hypothesized that these pathways are modulated by intense impact training which, in 72 
turn, is associated with the presence of low body weight, menstrual disturbances, and/or negative energy balance 73 
[14,17–20], leading, eventually, to impairment of bone mineralization. This phenomenon is known as the 74 
‘female athlete triad’ or ‘relative energy deficiency in sport’ (RED-S) [14,21] and has been recognised by 75 
several health organisations as a condition deserving appropriate monitoring and treatment [21–23]. However, 76 
several reports have suggested that low BMD in female elite athletes can occur without the presence of low body 77 
weight, menstrual disturbances or energy deficiency [24–28]. Moreover, far less is known in relation to male 78 
athletes. 79 
 Elite dancers represent an ideal population within impact sport athletes to investigate the association 80 
of SNPs in the ER and the Wnt/β-catenin signalling pathways with low bone mass phenotypes. Given that elite 81 
dancers are exposed to long hours of impact exercise regimens and to an environment that emphasizes leanness 82 
[29,30], the study of such individuals may shed light on the variability of bone anabolic responses to both 83 
exercise and osteoporosis risk factors (e.g. low body weight and fat mass). Dance training also offers a great 84 
model of mechanical loading since it may differently affect the peripheral and axial skeleton [8]. Consequently, 85 
the aim of the present study was to investigate the association of SNPs in the ER and the Wnt/β-catenin 86 
signalling pathways with low BMD phenotypes in a group of elite and pre-elite ballet dancers. 87 
 88 
MATERIALS AND METHODS 89 
Study population 90 
We used female and male pre-elite ballet dancers from a pre-elite dance school (offering full-time training to 91 
enter professional level; students have to audition for a place; 4-8 hours of training per day), and female and 92 
male elite dancers from a professional ballet company (6-8 hours of training per day). Pilot studies were 93 
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administrated in a group of pre-elite dancers in order to calculate the sample size needed for prevalence 94 
estimates. In a sample of 36 dancers and 36 matched-controls, low BMD (Z-score of <-2.0) at the lumbar spine 95 
(LS) was found in 36% and 6%, respectively. Based on this finding, we estimated that 41 participants were 96 
needed in each group to obtain 95% power, with α=0.05. 97 
 An introductory letter briefly describing the study was sent to the executive boards of the dance school 98 
and ballet company. Following the boards’ permission, pre-elite dancers (and respective guardians) and elite 99 
dancers were presented with the purposes of the study; 126 dance students (70.0%) and 41 elite dancers (68.3%) 100 
volunteered. All volunteers completed a questionnaire concerning their ethnicity, medical history, and 101 
past/current calcium/vitamin D supplementation. Eligible criteria included participants of white European origin, 102 
with no illnesses or treatments that might affect bone metabolism, not taking medication known to affect bone 103 
metabolism and no calcium/vitamin D supplementation (two dance students and one elite dancers were 104 
excluded). Women taking oral contraceptives and hormonal therapy were also excluded (one elite dancer). Based 105 
on these criteria, the studied population consisted of 151 elite ballet dancers and pre-elite dance students.  106 
The non-exercising participants (controls) were recruited from two local state schools and local 107 
Universities. Eligibility criteria were set according to the dancers’ characteristics, i.e. controls were only 108 
considered eligible if they were of the same sex, age (defined as decimal age; 12-months difference of a dancer) 109 
and race (white European-Caucasian) as dancers. Exclusion criteria included participation in organised physical 110 
activities/sports (i.e., beyond school curriculum for students; 2 sessions of physical education lessons at school, 111 
1/1.5 hours per session). Control participation was also restricted to those who had received/were receiving 112 
medications known to affect bone metabolism and to who reported illnesses/treatments that might affect bone 113 
metabolism. Out of the 282 responses (105 pupils, 177 university students), 151 that fulfilled the aforementioned 114 
criteria and were further included in the study. 115 
All participants provided signed informed consent according to the Declaration of Helsinki. The study 116 
was approved by the ethics committee of the Regional Administration of Health of Lisbon, Portugal 117 
(Proc.063/CES/INV/2012). 118 
 119 
Study design 120 
Study design and data collection are summarised in Figure 1. The study consisted in three phases. The first phase 121 
included a cross-sectional study in all elite dancers and pre-elite dance students (151 participants); these dancers 122 
were screened for the presence of low BMD and traditional osteoporosis risk factors (i.e. low body weight, 123 
menstrual disturbances, and low energy availability) considering current guidelines [21–23]. The second phase 124 
included a genetic association study in all recruited elite dancers, pre-elite dance students and aged- and sex-125 
matched controls (151 dancers and 151 controls). Finally, the third phase included a longitudinal assessment of a 126 
subgroup of 101 pre-elite dance students (and aged- and sex-matched controls) to evaluate the associations of 127 
sclerostin with bone mass gains. 128 
 129 
First phase (cross-sectional observations) 130 
All 151 elite ballet dancers and pre-elite dance students were screened for the presence of low BMD. The ISCD 131 
criterion for children was used to assess pre-elite dance students (the ISCD has adopted the term “low BMD” for 132 
a Z-score less than -2.0), and the ACSM guidelines [14] were adopted for our elite ballet dancers. The ACSM 133 
 5 
uses the term “low BMD” for a Z-score between -1.0 and -2.0 (along with secondary risk factors for stress 134 
fractures) and the term “osteoporotic” for a Z-score equal or less than -2.0 (along with secondary risk factors for 135 
stress fractures). Specifically, dancers were screened for the presence of low body weight (defined as a body 136 
mass index of <18.5 for adult participants; for children and adolescents, it was considered the body mass index 137 
expected for their age), low energy availability (<30.0 kcal/kgFFM/day), and, in case of female participants, 138 
menstrual disturbances (primary/secondary amenorrhea, oligoamenorrhea).  139 
 140 
Second phase (genetic associations) 141 
Genes related to low bone mass phenotypes and involved in mechanotransduction were identified according to 142 
literature reports [4,5]. This resulted in the identification of four genes: ESR1 and ESR2 (ER signalling pathway), 143 
as well as SOST and LRP5 (Wnt/β-catenin pathway). SNPs in or near these four genes reported to have a 144 
significant association with BMD variation and risk of osteoporosis in European populations were identified 145 
according to literature search [31]. The following SNPs were identified in SOST: rs851054, rs851056, 146 
rs10534024, rs4792909, rs9902563; LRP5: rs3736228, rs2306862, rs682429, rs491347, rs3781590, rs2508836, 147 
rs643892, rs312786; ESR1: rs2234693, rs9340799; ESR2: rs1256030, rs960070. 148 
Characteristics of each SNP were further examined using the Ensembl database, Hapmap and NCBI. 149 
Linkage disequilibrium (LD) analyses were performed using Haploview 4.1 with data retrieved from HapMap 150 
(CEU population). SNPs were then selected according to the following parameters: a) LD (R
2
) within each gene 151 
<0.8; b) distance from the promoter and 3’UTR <30Kb; and c) minor allele frequency (MAF) <0.2. The 152 
following eleven SNPs were selected for genotyping: SOST: rs851054, rs10534024; LRP5: rs682429, rs491347, 153 
rs2508836, rs587808, rs312786; ESR1: rs2234693, rs9340799; ESR2: rs1256030, rs960070. 154 
 155 
Third phase (longitudinal observations) 156 
All pre-elite dance students (n=115) and aged- and sex-matched controls included in the cross-sectional analysis 157 
were asked to participate on a follow-up study in order to analyse sclerostin serum concentration and bone mass 158 
throughout growth. Sixty-three female and 38 male pre-elite dance students (vs. 50 and 47 age- and sex-matched 159 
controls, respectively) volunteered. Data were collected annually for three consecutive years, from January 2013 160 
to March 2015. Details on the participants’ measurements and specific methodology appear in Figure 1. 161 
 162 
Anthropometry, menstrual, nutritional intake and energy availability 163 
Chronological age (obtained as decimal age) and anthropometry measurements were collected. Height, sitting 164 
height and body weight were measured in t-shirt, shorts and bare feet using a stadiometer (Seca, Seca217 165 
portable stadiometer, Hamburg, Germany) with accuracy of 0.1 cm and an electric scale (TANITA BC-418 MA 166 
Segmental Body Composition Analyser; Tanita Corporation, Tokyo, Japan) with an accuracy of 0.1 kg.  167 
All female participants were presented with a questionnaire to determine age at menarche, regularity of 168 
menstrual cycles and consumption of contraceptives. Amenorrhea was defined as the absence of menses for 169 
three consecutive months, whereas oligomenorrhea was considered when menstrual cycles occurred at intervals 170 
of greater than 35 days. 171 
Nutrient intakes were recorded via a 3-day food diary, previously validated [32]. Participants were 172 
asked to record all food and beverages consumed during two week days and one weekend day following 173 
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appropriate instructions. The software Food Processor SQL Edition, version 9.8.1 was used to estimate average 174 
energy and nutrition intakes. During the week that nutrition information was collected, energy expenditure was 175 
also estimated using an accelerometer – SenseWear [33] for 7 consecutive days. Energy availability was further 176 
estimated using standard protocols (http://www.femaleathletetriad.org/calculators/); information on dietary 177 
energy intake (provided by the food diary), exercise energy expenditure (information retrieved from the 178 
accelerometer), and body fat percentage (measured by DXA) was used for the estimation of energy availability.  179 
 180 
Hormonal analysis 181 
Blood samples were collected in early morning after an 8-hour fasting. Blood samples were submitted to 182 
centrifugation at 2500g for 10 min; serum samples were stored at -80ºC until they were analysed. Serum 183 
sclerostin concentrations were measured by an ELISA assay kit (Human SOST/Sclerostin Quantikine ELISA 184 
Kit, Ref DSST00), from R&D Systems, Inc. (Minneaplolis, MN 55413, USA). The intra-assay and inter-assay 185 
CV’s ranged between 1.8-2.1% and 8.2-10.8%, respectively.  186 
 187 
Genotyping 188 
Genomic DNA was isolated from blood using the MagNA Pure LC DNA isolation kit (Roche, Switzerland) 189 
according to product specifications. Primers were generated from the genomic sequence using Primer-BLAST 190 
and its specificity determined using BLASTn. DNA was amplified with the QIAGEN Multiplex PCR Kit 191 
(Qiagen, Germany), either in single PCR reactions (SNP rs312786) or in two sets of multiplex reactions (set 1: 192 
SNPs rs2234693, rs960070, rs682429, rs587808 and rs851054; set 2: SNPs rs9340799, rs1256030, rs491347, 193 
rs2508836 and rs10534024). PCR products were purified using Sephadex G-50 fine (Sigma-Aldrich, USA) 194 
columns on a filtration plate and genotypes determined using the Genetic Analyzer 3130 and 3130xl (Applied 195 
Biosystems). 196 
 197 
Bone measurements 198 
BMD at the LS, FN and forearm (1/3 distal radius) were measured using DXA. Participants were assessed in two 199 
different centres using Dual-energy X-ray absorptiometry (DXA): Lunar (GE Lunar Prodigy) and Hologic 200 
(Discovery Wi). For consistency, the same certified technician performed all scans and analyses at both centres 201 
in each year. The data obtained from the two machines were homogenised by following the procedure described 202 
elsewhere [34].  203 
 204 
Statistical analyses 205 
First phase (cross-sectional observations): Independent t-tests were used to compare descriptive characteristics 206 
and unadjusted values of bone measurements between dancers with low BMD and dancers with normal BMD. 207 
Bone parameters were further compared between elite dancers with low BMD with elites with normal BMD 208 
after adjustment for age, sex and primary amenorrhea using analysis of covariance (ANCOVA). ANCOVA was 209 
also used to estimate bone mass values in pre-elite dance students’ bone mass values after the adjustment for sex, 210 
energy availability, fat, calcium and carbohydrates intakes.  211 
Second phase (genetic associations): Independent t-tests were used to compare general characteristics between 212 
dancers and controls (stratified by bone mass phenotypes). Hardy-Weinberg equilibrium (HWE) of alleles at 213 
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individual loci (level of significance set at p<0.01) was measured at the level of the control population. 214 
Association of genotypes with study groups (defined according to bone mass status: dancers with normal BMD 215 
vs. dancers with low BMD, and controls with normal BMD vs. dancers with low BMD) and independence of 216 
SNPs were assessed by unconditional logistic regression with the “SNPassoc” package implemented in R. The 217 
minor allele of most SNPs is the ancestral allele and, thus, it has been selected as the reference allele in all 218 
analysis. Four hereditary models were considered in the analysis (codominant, dominant, recessive and log-219 
additive) and included the variable weight. Other confounding variables such as sex and age were not included in 220 
the models because the BMD measurements were performed according to references that already included 221 
adjustment for those variables. The adjustment for multiple testing was performed by the false discovery rate 222 
(FDR) method. Haplotype frequencies were inferred using the “haplo.stats” package implemented in R. 223 
Haplotype association with the study groups (OR, 95% CI and p values) was assessed for those with a minimum 224 
haplotype frequency of 0.01 and using as reference the most frequent haplotype. 225 
Third phase (longitudinal observations): Independent t-tests were used to compare general characteristics 226 
between pre-elite dance students and aged- and sex-matched controls at each measured occasion. Bone mass 227 
values were adjusted for sex and serum sclerostin concentrations using ANCOVA. Analyses in all phases were 228 
performed with SPSS v.20.0 and statistical significance was set at p<0.05.  229 
 230 
RESULTS 231 
First phase (cross-sectional observations)  232 
Some dancers revealed low BMD, but did not display any traditional osteoporosis risk factors (and vice-versa). 233 
Specifically, out of the 151 elite ballet dancers and pre-elite dance students, 80 were identified with low BMD 234 
(Figure 2). Out of these 80 athletes, 56.3% had at least one traditional osteoporosis risk factor, whereas 28.6% 235 
were diagnosed with low BMD but did not display any risk factor. In contrast, 37.2% revealed one or more 236 
traditional osteoporosis risk factors, but had normal BMD (Figure 2). 237 
General characteristics of the 151 elite ballet dancers and pre-elite dance students are displayed in Table 238 
S1 (Supplement); briefly, all bone mass parameters were significantly attenuated in dancers with low BMD 239 
compared to the ones with normal BMD. Table S2 (Supplement) shows that following adjustments for sex, 240 
energy availability, and nutrition intake (energy, fat, calcium, carbohydrates), elite dancers previously identified 241 
with low BMD continued to display a significant lower BMC and BMD values at the forearm compared with 242 
their counterparts with normal BMD (BMC: p<0.05; BMD: p<0.01). Similarly, pre-elite dancers with low BMD 243 
also displayed significantly lower bone mass parameters compared with pre-elite dancers with normal BMD at 244 
all anatomical sites (FN BMC/ BMD: p<0.001; LS BMC: p<0.001; forearm BMD: p<0.001).  245 
 246 
Second phase (genetic associations) 247 
Genetic variants at the ER and the Wnt/β-catenin signalling pathways were found to be risk factors for low BMD 248 
in dancers at both impact and non-impact sites. Table S3 (Supplement) shows selected characteristics of the 249 
genotyped SNPs. Three SNPs [rs682429 (LRP5), rs851054 and rs10534024 (SOST)] were significantly deviated 250 
from the Hardy-Weinberg Equilibrium (p<0.01) and were not further considered. Table 1 shows the association 251 
of SNPs in LRP5, ESR1 and ESR2 with bone mass phenotypes comparing elite and pre-elite dancers with normal 252 
BMD (reference) and dancers with low BMD. The T allele in rs2234693 (ESR1) was associated with low BMD 253 
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at the LS [OR (CI)=1.77 (1.06-2.97), p=0.026). However, this association was not retained after FDR correction. 254 
Considering the SNP rs9340799 (ESR1), the A allele (dominant model) was associated with low BMD in elite 255 
and pre-elite at the forearm [OR (CI)=10.74 (1.37-83.98), p=1.9x10
-3
]. The genotypes AG and AA were 256 
significantly associated with low BMD at the forearm with an OR of 10.63 (1.32-85.87) and 10.85 (1.35-87.36), 257 
respectively (p=8.2x10
-3
).  258 
Table 2 shows the distribution of genotypes in controls with normal BMD (reference) and dancers with 259 
low BMD. Considering SNP rs2508836 (LRP5), the C allele was associated with low BMD in dancers 260 
(dominant model) at the LS [OR (CI)=6.90 (1.27-37.49), p=1.0x10
-3
]. Considering SNP rs9340799 (ESR1), there 261 
was a significant difference in genotype frequencies between normal controls and dancers with low BMD at the 262 
forearm (p=0.019), LS (p=0.021) and FN (p=0.020). The A allele (log-additive model) significantly increased 263 
the odds of low BMD in elite and pre-elite dancers at the forearm [OR (CI)=1.95 (1.09-3.51), p=0.020],
 
LS [OR 264 
(CI)=2.32 (1.24-4.32), p=5.8x10
-3
] and FN [OR (CI)=2.45 (1.26-4.74), p=5.2x10
-3
]. The association of the A 265 
allele with low BMD in dancers was also observed in the dominant model at the forearm [OR (CI)=8.37 (1.07-266 
65.26), p=7.0x10
-3
], and in the recessive model at the LS [OR (CI)=2.98 (1.30-6.87), p=9.3x10
-3
] and FN [OR 267 
(CI)=3.08 (1.26-7.51), p=0.012]. All aforementioned associations regarding rs9340799 SNP were retained after 268 
FDR correction. The only significant association retained after FDR correction was at LS for SNP rs9340799 in 269 
ESR1. The A allele was significantly associated with low BMD [OR (CI)=2.10 (1.22-3.62), p=5.4x10
-3
], an 270 
association already observed in dancers with low BMD.  271 
Table S4 (Supplement) demonstrates an inverse association with low BMD at the FN in dancers with 272 
haplotype CG in ESR1 [OR (CI)=0.53 (0.29-0.96), p=0.037]. Haplotype analysis also revealed that, within the 273 
same anatomical site, the odds of low BMD were significantly increased in dancers with the haplotype GCGT in 274 
LRP5 [OR (CI)=8.97 (1.14-70.31), p=0.037]. Haplotype association tests considering normal controls 275 
(reference) and dancers with low BMD showed the CG haplotype in ESR1 was inversely associated with low 276 
BMD at the LS [OR (CI)=0.43 (0.22-0.82), p=0.001] and at the FN [OR (CI)=0.39 (0.19-0.80), p=0.010]. In 277 
LRP5, haplotype GCAG was significantly associated with low BMD at the forearm in dancers [OR (CI)=6.43 278 
(1.33-31.14) p=0.021] and haplotype GCGT was associated with low BMD at the LS [OR (CI)=12.7 (1.22-279 
132.18) p=0.033]. 280 
 281 
Third phase (longitudinal observations) 282 
Serum sclerostin concentrations were increased throughout the 3-year study in pre-elite dance students compared 283 
to controls. Indeed, at baseline and at 1-yr follow-up, female pre-elite dancers revealed significantly higher 284 
sclerostin values than their controls (p<0.001) (Figure 3). No significant difference was found in serum 285 
sclerostin concentrations between male pre-elite dance students and their controls. Bone mass values were 286 
further adjusted for sex and sclerostin serum concentrations; after the adjustment, no differences in BMC and 287 
BMD between groups were seen at the FN and LS (p>0.05) (Table S5; Supplement). 288 
 289 
DISCUSSION 290 
The present study used elite and pre-elite dancers as a group representing individuals participating in impact 291 
sports and showed that they are exhibiting very high prevalence (52.98±7.96 %) of low BMD. Moreover, we 292 
found that the low BMD in these individuals is not explained by factors usually associated with bone mass in 293 
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athletes (i.e. body weight, menstrual disturbances, energy deficiency). Indeed, after adjusting for these factors, 294 
individuals with low BMD continued to display lower bone mass values at both impact and non-impact sites. 295 
More importantly, the present study shows, for the first time, that selected gene polymorphisms of the ER and 296 
the Wnt/β-catenin signalling pathways are significantly associated with low BMD in elite impact sport athletes. 297 
Specifically, the ESR1 rs9340799 A allele, LRP5 rs2508836 C allele and LRP5 GCGT/GCAG haplotypes were 298 
associated with increased odds of low BMD at both impact (LS and FN) and non-impact sites (forearm). 299 
Furthermore, we found that serum sclerostin, a protein that inhibits bone formation by blocking the action of the 300 
Wnt in osteoblasts [35], was significantly increased in dancers compared to controls. Taken together, these 301 
results suggest that the ER and Wnt/β-catenin signalling pathways may be critical in determining bone mass 302 
phenotypes in elite impact sport athletes. 303 
Results from clinical research show that dancers are at higher risk for developing low BMD and 304 
osteoporosis compared to the general population [36–38], yet the mechanistic physiology to explain this 305 
phenomenon remains poorly understood [39]. Previous research highlighted that the exercise-induced response 306 
to mechanical stress by osteoblast lineage cells requires full ESR1 and LRP5 activity [6,40]. The present study 307 
showed that dancers C homozygotes for SNP rs2508836 in LRP5, dancers ESR1 rs9340799 A-carries, and 308 
dancers LRP5 GCGT and GCAG haplotype-carriers have increased odds for developing low BMD at both 309 
impact and non-impact sites. Therefore, it can be hypothesized that the degree to which each individual responds 310 
to mechanical stress from dance training stimuli is associated with their genetic background. This is further 311 
supported by observations in mice lacking functional ESR1, which show a 70% attenuation of the osteogenic 312 
response to loading [41,42], as well as the fact that the Lrp5 co-receptor is regulating osteoblast activity 313 
following loading [6,7]. Based on these key roles of ESR1 and LRP5 in the regulation of mechanical loading, it 314 
can be speculated that the ESR1 rs9340799 and LRP5 rs2508836 modulated our athletes’ skeletal response to 315 
exercise.  316 
It should be highlighted that BMD phenotypes are not inherited in a Mendelian manner, since low 317 
BMD onset and progression are influenced by genetic factors modulated by environmental elements [43]; the 318 
results of the present study may express this view. Comparing controls with normal BMD (not receiving exercise 319 
stimuli) to dancers with low BMD (receiving exercise stimuli), it was observed that ESR1 rs9340799 A allele 320 
and LRP5 rs2508836 C allele were associated with increased odds of low BMD in dancers, not only at non-321 
impact sites, but at impact sites too. In turn, comparing dancers with normal BMD with dancers with low BMD 322 
(both groups receiving exercise stimuli), only the ESR1 rs9340799 A allele was associated with increased odds 323 
of low BMD at non-impact sites only. Since the associations between the risk alleles and phenotypes at impact 324 
sites are not manifested when comparing dancers with normal BMD and dancers with low BMD (both groups 325 
receiving exercise stimuli), it could be hypothesised that genetic and environmental factors were interacting 326 
closely in determining dancers’ bone mass phenotypes. However, randomized control trials are needed to 327 
confirm this hypothesis.  328 
Both rs9340799 and rs2508836 are located in introns 1. First introns can affect gene transcription, 329 
polyadenylation, mRNA export, translational efficiency, rate of mRNA decay, and may also alter transcription 330 
factors binding sites [44–46]. Therefore, it seems logical to suggest that one of these processes influenced 331 
expression levels of ESR1 and LRP5 and, consequently, susceptibility for low BMD phenotypes in our study. 332 
Previous research in other population groups (e.g., post-menopausal women, elderly young adults, adolescents) 333 
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also reported associations between rs9340799 and rs2508836 and bone mass phenotypes [31]. However, the 334 
mechanisms by which these SNPs may affect gene function and, ultimately, bone phenotypes remain unknown. 335 
Also, the possibility that the present associations are due to linkage disequilibrium with others, causally 336 
associated, SNPs cannot be excluded. 337 
Osteocytes mediate the osteogenic response from mechanical loading through sclerostin (encoded by 338 
the SOST gene) [35]; SOST downregulation is associated with bone mass gains, whereas overexpression of 339 
SOST has been linked with low bone mass phenotypes [35,47]. Intervention studies in humans showed reduced 340 
levels of serum sclerostin following exercise stimuli, resulting in bone mass gains [48,49]. Therefore, the 341 
athletes participating in the third phase of this study (longitudinal observations) would be expected to 342 
demonstrate significantly lower sclerostin concentrations and higher bone mass values compared to controls, due 343 
to the osteogenic activity of their daily exercise training. In contrast, the athletes showed significantly higher 344 
sclerostin levels and lower BMD levels than controls. Moreover, these differences were not apparent after 345 
adjustment for sclerostin. Although the role of circulating sclerostin is not entirely clear, the aforementioned 346 
findings may indicate that this protein is inhibiting the Wnt/β-catenin pathway leading, eventually, to low BMD. 347 
However, since our population consisted of long-term elite athletes, their skeletons may have reached 348 
equilibrium and the loading impact of dancing may not be leading to a reduction in osteocyte sclerostin. 349 
Although no studies reporting the existence of an exercise stimuli threshold above which bone cells saturate 350 
were found, this hypothesis should not be excluded. As sclerostin is a key protein in Wnt/β-catenin, this pathway 351 
might be fundamental in determining bone mass phenotypes in impact sport athletes. 352 
Researchers and clinicians should be aware that low BMD in elite and pre-elite dancers might not be 353 
associated with the factors currently proposed by health organisations (i.e. body weight, menstrual disturbances 354 
and energy deficiency). The present study shows that the underlying pathophysiology of low BMD in these 355 
athletes relates to genetic factors influencing bone mass acquisition. Nevertheless, further exploration of the 356 
genes and signalling pathways involved in dancers’ adaptive response to exercise stimuli may yield a better 357 
understanding on the pathogenesis of low BMD in dancers, and may be useful in defining new therapeutic 358 
targets for clinical interventions. 359 
It is reasonable to assume that the present results may have been influenced by methodological 360 
limitations such as population stratification, a characteristic common in most genetic association studies. 361 
Considering the number of dancers (n=151) and age- and sex-matched controls genotyped (n=151 in each 362 
group), the present study has over 85% power to detect a modest genetic effect (OR of 2.0 and MAF=0.2). 363 
However, some power is lost after stratification, which may explain the lack of associations with other SNPs. 364 
Indeed, although our participants were matched for age, body weight, and sex, the matching for age was partly 365 
lost following stratification. Furthermore, stratification of the sample size might also justify the significant 366 
associations detected under different models for the same SNP (e.g. SNP rs9340799). Another limitation is that 367 
searching for the association of several SNPs with more than one phenotype can lead to increased risk for type I 368 
error (i.e., false-positives). To avoid this limitation, a multiple test correction (FDR) was applied. The present 369 
study included in the same group of dancers adults (who might be already experiencing bone mass losses) and 370 
children (who have not yet reached their peak bone mass). Although Z-scores, instead of BMD mean values, 371 
were used in order to overcome concerns due to the employment of a mixed group of dancers, it is recommend 372 
that future studies should consider to separate adult and children dancers for better clarification. Furthermore, it 373 
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would be interesting in future studies to collect data on the intensity of dance training and adjust data 374 
accordantly. Finally, it is important to note that our groups included both males and females because the 375 
distribution of Esr1 receptors in bone cells is similar among sexes [50]. Nevertheless, sex differences in the 376 
regulation of the Wnt/β-catenin signalling pathway should not be excluded; future studies should consider sexes 377 
separately to determine if one sex is influencing the genetic association or phenotypic variation more than the 378 
other.   379 
 380 
CONCLUSION 381 
Elite and pre-elite dancers demonstrate very high prevalence of low bone mineral density, which is likely related 382 
to genetic variants at the Wnt/β-catenin and ER signalling pathways and not to factors usually associated with 383 
bone mass in athletes (i.e. body weight, menstrual disturbances, energy deficiency).  384 
 385 
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